Harvey White | Medicine and Dentistry | Best Researcher Award

Prof. Harvey White | Medicine and Dentistry | Best Researcher Award

Health New Zealand - The Health Network | New Zealand

Author Profile

Scopus

Orcid 

Early Academic Pursuits

Prof. Harvey White’s journey into medicine began with a strong academic foundation that laid the groundwork for his pioneering career in cardiology. His advanced studies culminated in a Doctorate of Science from the University of Otago, where his thesis explored the prognostic importance of cardiac volume and vessel patency in the context of thrombolytic therapy. This formative academic phase instilled in him both a scientific curiosity and a commitment to evidence-based medicine, shaping the direction of his future clinical and research endeavors.

Professional Endeavors

Over the decades, Prof. White has held leading positions in cardiology, serving as a cardiologist and Director of the Cardiovascular Research Unit at Auckland City Hospital, while also contributing as an Honorary Clinical Professor at the University of Auckland. His clinical practice has been marked by a dedication to advancing the treatment of acute coronary syndromes, dyslipidemia, and cardiovascular diseases in the elderly. Beyond hospital walls, his advocacy for patient-centered care and public health initiatives has reinforced his reputation as both a clinician and a community leader.

Contributions and Research Focus

Prof. White has made remarkable contributions in areas such as antithrombotic therapy, the universal definition of myocardial infarction, and biomarker development for acute coronary syndromes. His investigations into lipid-lowering therapies, genetic markers, and cardiovascular outcomes have influenced guidelines and shaped clinical practice worldwide. He has consistently emphasized the integration of clinical trials, translational research, and collaborative studies, ensuring that his findings benefit both scientific communities and patients directly.

Accolades and Recognition

A highly cited researcher, Prof. White’s prolific publication record—spanning books, book chapters, peer-reviewed articles, and clinical guidelines—has earned him recognition among the world’s most influential scientific minds. He has been honored with prestigious awards, including the Prince Mahidol Award for Medicine, fellowship titles from leading cardiology societies, and multiple recognitions for his research excellence and thought leadership. His standing among the top global experts in cardiology reflects not only his scholarly output but also his enduring influence on international medicine.

Impact and Influence

The global impact of Prof. White’s work is evident in both academia and clinical practice. His leadership in redefining myocardial infarction classifications has guided generations of cardiologists, while his advocacy for evidence-based practices has transformed patient care protocols. His influence extends to policy, having advised the World Health Organization on cardiovascular disease prevention and diabetes management in developing nations. As a mentor and educator, he has inspired countless medical professionals to pursue excellence in research and practice.

Legacy and Future Contributions

Prof. White’s legacy is firmly established in the annals of cardiovascular medicine, yet his ongoing contributions suggest that his influence is far from complete. His continuous research into emerging therapies, his role in international collaborations, and his commitment to bridging scientific advancements with real-world healthcare challenges ensure that his impact will continue to grow. By championing innovation while prioritizing patient welfare, he sets a standard for the future of cardiology.

Publications


Article: Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Authors: Harvey D. White, Sean M. O’Brien, William E. Boden, Stephen E. Fremes, Sripal Bangalore, Harmony R. Reynolds, Gregg W. Stone, Ziad A. Ali, Neeraj Parakh, Jose Luis Lopez-Sendon, et al.
Journal: American Heart Journal
Year: 2025


Article: Great Debate: the universal definition of myocardial infarction is flawed and should be put to rest
Authors: Juan-Carlos Kaski, Christian Mueller, Harvey White, Pedro Lopez-Ayala, Ranil de Silva
Journal: European Heart Journal (Other publication type)
Year: 2025


Article: Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Authors: C. Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White, Serge Korjian, John H. Alexander, A. Michael Lincoff, Mark Heise, Bronwyn A. Kingwell, et al.
Journal: European Heart Journal
Year: 2024


Article: Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Authors: Andrew P. DeFilippis, J. Dawn Abbott, Brandon M. Herbert, Marnie H. Bertolet, Bernard R. Chaitman, Harvey D. White, Andrew M. Goldsweig, Tamar S. Polonsky, Rajesh Gupta, Caroline Alsweiler, et al.
Journal: Circulation
Year: 2024


Article: Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis
Authors: Rajan Rehan, Sohaib Virk, Christopher C. Y. Wong, Freda Passam, Jamie Layland, Anthony Keech, Andy Yong, Harvey D. White, William Fearon, Martin Ng
Journal: Heart
Year: 2024


Conclusion

Prof. White’s biography is a testament to the profound difference that one individual can make in shaping modern medicine. His achievements reflect not only a personal dedication to research and patient care but also a broader vision for global cardiovascular health. His legacy, defined by innovation, leadership, and compassion, will inspire future generations of clinicians and researchers to carry forward the mission of improving lives through science and medicine.

Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Guangdong Provincial Laboratory of Traditional Chinese Medicine | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Li’s academic path began with an exceptional undergraduate performance in Chemistry at Jilin University. Her passion for science led her to pursue a Master’s degree in Analytical Chemistry and subsequently a Ph.D. in the same field, which she completed in July 2014 under the guidance of esteemed professor Zhang Shusheng. During her doctoral studies, she received comprehensive training in analytical techniques and developed a strong interest in practical applications related to food and environmental safety.

🏢 Professional Endeavors

In 2014, Dr. Li joined the School of Public Health at Jilin University as a faculty member. She steadily rose through the ranks to become a full professor and doctoral supervisor. Her responsibilities have included leading multiple high-level national projects, mentoring graduate students, and engaging in collaborative research across disciplines. She has become a pivotal figure in shaping the academic direction of the university’s public health research programs.

🔬 Contributions and Research Focus

Dr. Li’s research primarily focuses on food safety risk assessment, monitoring of toxic and hazardous substances in the food chain, and the development of advanced analytical methods. She has published over 80 high-impact academic papers, including articles in Analytical ChemistryBiosensors and BioelectronicsACS Sensors, and TrAC Trends in Analytical Chemistry. Her work integrates innovative electrochemical and optical biosensing techniques, making significant advancements in the detection of pesticide residues, foodborne pathogens, and environmental pollutants.

🏆 Accolades and Recognition

Her excellence has not gone unnoticed. Dr. Li has received several prestigious honors, including the “Young Elite Scientists Sponsorship Program” by the China Association for Science and Technology and the First Prize for Scientific and Technological Progress by the Jilin Provincial Government. She has also served as a visiting scholar at the University of Michigan, where she broadened her international research collaboration network.

🌍 Impact and Influence

Dr. Li's research has had a profound impact on public health, food regulation, and environmental policy. Her cutting-edge methodologies contribute directly to national standards and have been implemented in real-world food safety monitoring. She is also an active member of professional organizations and frequently serves as a reviewer for top-tier scientific journals, thereby shaping the future of analytical science and public health on both national and global scales.

🔮 Legacy and Future Contributions

Looking forward, Dr. Yuanyuan Li is poised to continue her groundbreaking work in biosensor development and integrated health risk assessment. Her vision is to establish more comprehensive detection platforms that can safeguard food and environmental quality, ultimately enhancing public health resilience. As a mentor, researcher, and innovator, her legacy is one of rigorous science combined with a deep commitment to societal well-being.

 

Publications


📄 Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation

Authors:
De-Sheng Xu, Yan Wang, Zi-Rui Li, Ping-Li Mo, Ming-Tai Chen, Rui-Zhi Zhao, Zheng Fan, Wen-Jie Mo, Qi-Lu Li, Fang-Cao Pi, Qi-Di Sun, Juan-Min Li, Yun-Da Yao, Jian-Ping Chen, Yuan-Yuan Li, Jie-Nan Luan, Shang-Bin Zhang, Ying Xie, Hua Zhou

Journal: Pharmacological Research   Year: 2025


📄 Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice

Authors:
W.-T. Wang, Y.-Y. Zhang, Z.-R. Li, J.-M. Li, H.-S. Deng, Y.-Y. Li, H.-Y. Yang, C.-C. Lau, Y.-J. Yao, H.-D. Pan, L. Liu, Y. Xie, H. Zhou et al.

Journal: Phytomedicine   Year: 2024


📄 A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment

Authors:
M.-T. Chen, F.R. Huang, B.-H. Chen, J.-L. Kang, Y.-J. Yao, M.-N. Liu, Y.-Y. Li, Y.-Q. Li, T.-R. Zhou, D.-T. Peng, L.-D. Luo, C.-S. Wei, Y.-F. Xing, Q.-B. Wu, H. Zhou, G.-D. Tong

Journal: Biomedicine & Pharmacotherapy   Year: 2023